Influence of Carbohydrate on Amino Acid Absorption From Dietary Protein (ICADP)

NCT03303729 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-02-27

No results posted yet for this study

Summary

10 young males will be recruited to participate in a randomized double blinded crossover study to investigate the influence of concomitant intake of two different types of carbohydrate with protein hydrolysate on the absorption kinetics of protein-derived amino acids and the impact on myofibrillar protein synthesis. During the trial days the subjects will perform a bout of whole body resistance exercise and ingest a supplement of meat hydrolysate labeled with D5-phenylalanine together with randomized and double blinded type of carbohydrate consisting of either glucose or cluster dextrin.

The primary outcome is the time to obtain peak concentration of D5-phenylalanine after intake of meat hydrolysate with either glucose or cluster dextrin.

Hypotheses:

I) The cluster dextrin will increase the absorption of the amino acids from the meat hydrolysate, and thereby result in a faster rise and a higher peak in plasma amino acid concentration in the postprandial period.

II) The meat hydrolysate will increase the protein synthesis rate to a higher extent when combined with cluster dextrin than with glucose.

Conditions

  • Muscle Protein Synthesis
  • Amino Acid

Interventions

DIETARY_SUPPLEMENT

Meat Hydrolysate

25 grams of meat hydrolysate to maximally stimulate protein synthesis.

DIETARY_SUPPLEMENT

Cluster Dextrin

75 grams of Cluster Dextrin

DIETARY_SUPPLEMENT

Placebo

75 grams of Glucose

Sponsors & Collaborators

  • University of Birmingham

    collaborator OTHER
  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Jacob L. Bülow, MD · Bispebjerg Hospital

  • Lars Holm, Prof. · University of Birmingham

  • Michael Kjaer, MD, prof. · Bispebjerg Hospital

  • Sofus Sølyst, stud.med. · University of Copenhagen

  • Mikkel Jensen, Stud.scient. · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-24
Primary Completion
2018-02-23
Completion
2018-02-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03303729 on ClinicalTrials.gov